JP2022508676A - 皮膚の老化および光老化の処置および予防に有効なペプチド - Google Patents

皮膚の老化および光老化の処置および予防に有効なペプチド Download PDF

Info

Publication number
JP2022508676A
JP2022508676A JP2021544961A JP2021544961A JP2022508676A JP 2022508676 A JP2022508676 A JP 2022508676A JP 2021544961 A JP2021544961 A JP 2021544961A JP 2021544961 A JP2021544961 A JP 2021544961A JP 2022508676 A JP2022508676 A JP 2022508676A
Authority
JP
Japan
Prior art keywords
peptide
group
cosmetic composition
skin
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021544961A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022508676A5 (enExample
Inventor
パブロ・ペッレグリーニ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C4T SRL
Original Assignee
C4T SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C4T SRL filed Critical C4T SRL
Publication of JP2022508676A publication Critical patent/JP2022508676A/ja
Publication of JP2022508676A5 publication Critical patent/JP2022508676A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021544961A 2018-10-11 2019-10-10 皮膚の老化および光老化の処置および予防に有効なペプチド Pending JP2022508676A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
IT102018000009384 2018-10-11
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Publications (2)

Publication Number Publication Date
JP2022508676A true JP2022508676A (ja) 2022-01-19
JP2022508676A5 JP2022508676A5 (enExample) 2022-10-18

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021544961A Pending JP2022508676A (ja) 2018-10-11 2019-10-10 皮膚の老化および光老化の処置および予防に有効なペプチド

Country Status (13)

Country Link
US (1) US20210395305A1 (enExample)
EP (1) EP3863728A1 (enExample)
JP (1) JP2022508676A (enExample)
KR (1) KR20210075098A (enExample)
CN (1) CN112823039A (enExample)
AU (1) AU2019357261A1 (enExample)
BR (1) BR112021006742A2 (enExample)
CA (1) CA3115025A1 (enExample)
EA (1) EA202190888A1 (enExample)
IL (1) IL282064B (enExample)
IT (1) IT201800009384A1 (enExample)
SG (1) SG11202103026YA (enExample)
WO (1) WO2020075108A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR102774179B1 (ko) * 2021-09-29 2025-03-04 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102726837B1 (ko) * 2021-09-29 2024-11-07 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102736940B1 (ko) * 2021-09-30 2024-12-03 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR102877905B1 (ko) * 2021-09-30 2025-10-30 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006312650A (ja) * 2000-08-24 2006-11-16 Univ California アテローム性動脈硬化症を改善する経口投与ペプチド
JP2010523598A (ja) * 2007-04-06 2010-07-15 カイ・ファーマシューティカルズ・インコーポレイテッド 痛みの軽減のためのガンマ阻害剤化合物の使用方法
EP2510980A1 (en) * 2008-10-23 2012-10-17 Edda De Carli A method for the dermocosmetic treatment of skin by application of NGF-containing compositions
JP2013523629A (ja) * 2010-03-25 2013-06-17 イプセン・マニュファクチャリング・アイルランド・リミテッド ペプチドの経皮投与方法
JP2013531005A (ja) * 2010-06-29 2013-08-01 アイエスピー インベストメンツ インコーポレイテッド 新規サーチュイン６活性化ペプチド及びそれを含有する化粧料または医薬組成物
JP2016210793A (ja) * 2010-11-18 2016-12-15 スティーヴン ヨーリン 毛髪成長のための組成物及び方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
AU7154698A (en) * 1997-04-25 1998-11-24 Genentech Inc. Ngf variants
US6919426B2 (en) 2002-09-19 2005-07-19 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
MEP31508A (hr) 2003-07-15 2010-10-10 Amgen Inc Humana anti-ngf neutrališuća antitijela kao selektivni ihibitori ngf signalne kaskade
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
KR101520333B1 (ko) * 2008-11-25 2015-05-14 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
EP2547365A1 (en) 2010-03-17 2013-01-23 Abbott Research B.V. Anti-nerve growth factor (ngf) antibody compositions
ITRM20110574A1 (it) * 2011-11-02 2013-05-03 Sampo S R L Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
EP3352853B1 (en) * 2015-09-22 2022-09-21 Johnson & Johnson Consumer Inc. Methods for enhancing topical application of a benefit agent
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN107286233B (zh) * 2016-04-13 2020-11-06 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848B (zh) * 2017-12-28 2020-10-16 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006312650A (ja) * 2000-08-24 2006-11-16 Univ California アテローム性動脈硬化症を改善する経口投与ペプチド
JP2010523598A (ja) * 2007-04-06 2010-07-15 カイ・ファーマシューティカルズ・インコーポレイテッド 痛みの軽減のためのガンマ阻害剤化合物の使用方法
EP2510980A1 (en) * 2008-10-23 2012-10-17 Edda De Carli A method for the dermocosmetic treatment of skin by application of NGF-containing compositions
JP2013523629A (ja) * 2010-03-25 2013-06-17 イプセン・マニュファクチャリング・アイルランド・リミテッド ペプチドの経皮投与方法
JP2013531005A (ja) * 2010-06-29 2013-08-01 アイエスピー インベストメンツ インコーポレイテッド 新規サーチュイン６活性化ペプチド及びそれを含有する化粧料または医薬組成物
JP2016210793A (ja) * 2010-11-18 2016-12-15 スティーヴン ヨーリン 毛髪成長のための組成物及び方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ACS CHEM. NEUROSCI., vol. 6, JPN6023049618, 2015, pages 1379 - 1392, ISSN: 0005354890 *
CHEM. EUR. J., vol. 17, JPN6023049617, 2011, pages 3726 - 3738, ISSN: 0005354891 *
J. BIOL. CHEM., vol. 282, JPN6023049619, 2007, pages 27557 - 27561, ISSN: 0005354892 *
YAKUGAKU ZASSHI, vol. 127, JPN6023049616, 2007, pages 655 - 662, ISSN: 0005354893 *

Also Published As

Publication number Publication date
EA202190888A1 (ru) 2021-07-07
KR20210075098A (ko) 2021-06-22
EP3863728A1 (en) 2021-08-18
AU2019357261A1 (en) 2021-05-13
BR112021006742A2 (pt) 2021-09-21
IL282064A (en) 2021-05-31
SG11202103026YA (en) 2021-04-29
WO2020075108A1 (en) 2020-04-16
US20210395305A1 (en) 2021-12-23
IL282064B (en) 2022-09-01
IT201800009384A1 (it) 2020-04-11
CA3115025A1 (en) 2020-04-16
CN112823039A (zh) 2021-05-18

Similar Documents

Publication Publication Date Title
US20210395305A1 (en) Peptide for cosmetic application
DE69907577T2 (de) Entzündungshemmende Zusammensetzung
JP2024075684A (ja) 皮膚症状を改善するためのポリペプチドおよび方法
JP2006513231A (ja) 皮膚代謝生理活性物質
CN107080831A (zh) 短抗微生物脂肽
US12162956B2 (en) Peptides and methods for reducing skin pigmentation
CA2784516C (en) Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
DE102004028300B4 (de) Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind
JP7854982B2 (ja) 皮膚科領域における治療用途のためのペプチド
US20040043463A1 (en) Peptide-tagged proteins and compositions for regulating features of the skin or hair; methods of making, and methods of using thereof
KR102089754B1 (ko) 피부투과성이 개선된 탈모 억제 또는 발모 촉진용 조성물
KR102533223B1 (ko) 아토피 피부염 개선 또는 예방용 펩타이드 및 이를 포함하는 경피 흡수가 개선된 화장료 조성물
US9566222B2 (en) Peptidyl arginine deiminase 1 and/or 3 activator compounds in the epidermis and uses thereof
JP7668106B2 (ja) Ｔｒｐｖ３活性化剤
JP7503503B2 (ja) 炎症性成分を有する皮膚または粘膜の罹患を予防および処置するための化合物
EP3852781B1 (en) Compositions comprising acylated tetrapeptides for dermatological and cosmetic applications
KR20110136371A (ko) 소목 및 세포침투성 ｈｓｐ27 융합단백질을 포함하는 항염증 피부외용제 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221007

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20230213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231205

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240229

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240625